Literature DB >> 33280477

Covid-19 infection-induced neuromyelitis optica: a case report.

Melike Batum1, Aysin Kisabay Ak1, Hatice Mavioğlu1.   

Abstract

INTRODUCTION: Acute respiratory syndrome coronavirus-2 (Covid-19) can infect the respiratory system, as well as the central, peripheral nervous system, and muscles, leading to neurological symptoms and signs. The most common neurological symptoms are dizziness, headache, impaired consciousness, ataxia, hypogosis, hyposmia, neuralgia, and myalgia. The most common neurological diseases are acute cerebrovascular disease, epilepsy, acute hemorrhagic necrotizing encephalopathy, miyelitis, and Gullian-Barre syndrome.
METHODS: In this case report, a patient infected with Covid-19 and diagnosed as neuromyelitis optica (NMO) with anamnesis, clinical and radiological findings is presented.
RESULTS: A 50-year-old woman presented with weakness of both legs, urine retention, high fever, and cough. Spinal magnetic resonance imaging revealed expensive long-segment and centrally located demyelinating lesion extending from the cervical cord (at the level of C3) to the conus. Thoracic-computerized tomography revealed consolidation areas located on the lower segments of bilateral lungs and ground-glass density, air bronchograms, and peribronchial thickening surrounding these areas. Aquaporin-4 immune globulin-G was found to be positive.
CONCLUSION: It was considered appropriate to present this case because of being the first case of parainfectious NMO considered to be induced by SARS-CoV-2.

Entities:  

Keywords:  Covid-19; demyelinating lesion; neuromyelitis optica; parainfectious myelitis; spinal cord

Mesh:

Substances:

Year:  2020        PMID: 33280477     DOI: 10.1080/00207454.2020.1860036

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.590


  7 in total

Review 1.  Biosensing surfaces and therapeutic biomaterials for the central nervous system in COVID-19.

Authors:  Amene Saghazadeh; Nima Rezaei
Journal:  Emergent Mater       Date:  2021-03-10

2.  A Single-Health System Case Series of New-Onset CNS Inflammatory Disorders Temporally Associated With mRNA-Based SARS-CoV-2 Vaccines.

Authors:  Ahmad A Ballout; Anna Babaie; Michael Kolesnik; Jian Yi Li; Natasha Hameed; Glenn Waldman; Frasat Chaudhry; Sami Saba; Asaff Harel; Souhel Najjar
Journal:  Front Neurol       Date:  2022-02-24       Impact factor: 4.003

3.  Para and Post-COVID-19 CNS Acute Demyelinating Disorders in Children: A Case Series on Expanding the Spectrum of Clinical and Radiological Characteristics.

Authors:  Abdulhafeez M Khair; Rahul Nikam; Sumair Husain; Melanie Ortiz; Gurcharanjeet Kaur
Journal:  Cureus       Date:  2022-03-22

Review 4.  Nervous system manifestations related to COVID-19 and their possible mechanisms.

Authors:  Zhen Xie; Hao Hui; Zhihan Zhao; Wenjin Yu; Rui Wu; Yanzhao Zhu; Yuan Song; Bingqing Cao; Wenzhen Shi; Di Zhao; Yunsong Zhao; Junchao Lv; Qian Yao; Yan Duan; Jingwen Li; Haijun Zhang; Linfu Zhou; Xiaotian Wang; Ye Tian; Gang Zhao
Journal:  Brain Res Bull       Date:  2022-06-28       Impact factor: 3.715

5.  Neuromyelitis optica spectrum disorder post-COVID-19 infection: A rare case report from Northeast India.

Authors:  Dipankar Das; Harsha Bhattacharjee; Obaidur Rehman; Nilutparna Deori; Damaris Magdalene; Gayatri Bharali; Sakshi Mishra; Kanika Godani
Journal:  Indian J Ophthalmol       Date:  2022-05       Impact factor: 2.969

6.  COVID-19 and the risk of CNS demyelinating diseases: A systematic review.

Authors:  Itay Lotan; Shuhei Nishiyama; Giovanna S Manzano; Melissa Lydston; Michael Levy
Journal:  Front Neurol       Date:  2022-09-20       Impact factor: 4.086

7.  Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19.

Authors:  Shuai Chen; Xiao-Rui Fan; Shuang He; Jie-Wen Zhang; Shu-Jian Li
Journal:  Neurol Sci       Date:  2021-06-29       Impact factor: 3.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.